<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Rural Pharmacy and Prescription Drugs resources via the Rural Health Information Hub</title>
    <link>https://www.ruralhealthinfo.org/topics/pharmacy-and-prescription-drugs</link>
    <description>Rural Pharmacy and Prescription Drugs resources related to rural health, with information provided by the Rural Health Information Hub</description>
    <language>en</language>
    <copyright>Copyright 2026 Rural Health Information Hub</copyright>
    <item>
      <title>News: Public Inspection: CMS: Request for Information: Pharmacy Benefit Manager Compensation and Data Collection</title>
      <link>https://www.federalregister.gov/public-inspection/2026-12344/request-for-information-pharmacy-benefit-manager-compensation-and-data-collection</link>
      <description>Pre-publication notice from the Centers for Medicare &amp; Medicaid Services (CMS) seeking comments on a request for information (RFI) regarding technical input on the services and business practices of pharmacy benefit managers (PBMs) and their affiliates to inform implementation of recent legislation. The RFI specifically focuses on two specific legislative requirements that are effective beginning calendar year 2028: 1) restrictions on the remuneration that PBMs and their affiliates may receive for services in connection with the utilization of covered Part D drugs and 2) data reporting requirements. Comments are due within 30 days of the publication of this notice, which is scheduled for June 18, 2026.</description>
      <guid>https://www.ruralhealthinfo.org/news/38661</guid>
      <pubDate>Wed, 17 Jun 2026 08:50:58 -0500</pubDate>
    </item>
    <item>
      <title>News: CMS: Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program</title>
      <link>https://www.federalregister.gov/documents/2026/06/16/2026-12059/medicare-drug-price-negotiation-program-and-medicare-prescription-drug-benefit-program</link>
      <description>Notice of proposed rule from the Centers for Medicare &amp; Medicaid Services (CMS) that would codify the Medicare Drug Price Negotiation Program, establish certain new policies for the Negotiation Program and the Medicare Prescription Drug Benefit Program as required by the Inflation Reduction Act of 2022, and propose a modification to the fixed combination drug policy. Comments are due by August 17, 2026.</description>
      <guid>https://www.ruralhealthinfo.org/news/38651</guid>
      <pubDate>Mon, 15 Jun 2026 09:20:01 -0500</pubDate>
    </item>
    <item>
      <title>News: HRSA: Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-NEW</title>
      <link>https://www.federalregister.gov/documents/2026/06/15/2026-11989/agency-information-collection-activities-proposed-collection-public-comment-request-information</link>
      <description>Notice from the Health Resources and Services Administration (HRSA) seeking comments on a proposed information collection request (ICR) titled "340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB No. 0906-NEW." HRSA's Office of Pharmacy Affairs (OPA) intends to introduce a revised 340B Rebate Model Pilot Program (Pilot) as a mechanism for qualifying drug manufacturers, who wish to participate, to effectuate the 340B ceiling price on a limited set of drugs sold to covered entities using rebates. This ICR includes the collection of proposed rebate model plans from qualifying drug manufacturers, the ongoing collection of sales data from drug manufacturers to allow OPA to monitor implementation of the Pilot and enhance 340B program integrity and compliance monitoring, and the collection of data submitted by covered entities to manufacturers to request a rebate under a potential Pilot. Comments are due by July 15, 2026.</description>
      <guid>https://www.ruralhealthinfo.org/news/38648</guid>
      <pubDate>Mon, 15 Jun 2026 09:00:29 -0500</pubDate>
    </item>
    <item>
      <title>Resource: Analysis of 340B Program Impact on Rural Hospitals</title>
      <link>https://340breform.org/wp-content/uploads/2026/05/Analysis-of-340B-Program-Impact-on-Rural-Hospitals-1.pdf</link>
      <description>Examines the impact of the 340B program on rural hospitals and their patients. Provides data on rural versus urban payers and patient demographics, utilization of 340B drugs under Medicare Part B, financial metrics, and more.</description>
      <guid>https://www.ruralhealthinfo.org/resources/28033</guid>
      <pubDate>Fri, 29 May 2026 10:17:53 -0500</pubDate>
    </item>
    <item>
      <title>News: Pharmacy Receives NACDS Foundation Award To Reach Students in Rural Communities</title>
      <link>https://wire.auburn.edu/content/pharmacy/2026/05/content-item.php</link>
      <description>Auburn University's Harrison College of Pharmacy was awarded a $20,000 National Association of Chain Drug Stores (NACDS) Foundation scholarship. The award will support the school's Rural RxGuidance program, designed to inspire rural youth to consider pharmacy careers, while addressing workforce shortages in medically underserved areas.</description>
      <guid>https://www.ruralhealthinfo.org/news/38574</guid>
      <pubDate>Fri, 22 May 2026 09:38:23 -0500</pubDate>
    </item>
    <item>
      <title>News: New Program Could Bring Low-Cost Generic Drugs to Rural Hospitals</title>
      <link>https://www.wyomingpublicmedia.org/health/2026-05-20/new-program-could-bring-low-cost-generic-drugs-to-rural-hospitals</link>
      <description>The Helmsley Charitable Trust is funding a pilot program through the Civica Foundation that will give participating hospitals access to a consistent supply of drugs at wholesale prices, without having to buy in bulk. Dozens of independent hospitals in rural areas of Montana, Nevada, and Wyoming are eligible.</description>
      <guid>https://www.ruralhealthinfo.org/news/38567</guid>
      <pubDate>Thu, 21 May 2026 09:02:06 -0500</pubDate>
    </item>
    <item>
      <title>Event: 2027 Annual 340B Coalition Winter Conference</title>
      <link>https://340bcoalition.org/events/</link>
      <description>San Diego CA&lt;br&gt;February 22, 2027</description>
      <guid>https://www.ruralhealthinfo.org/events/25227</guid>
      <pubDate>Mon, 18 May 2026 14:46:53 -0500</pubDate>
    </item>
    <item>
      <title>Resource: Where Primary Care and Clinical Pharmacy Services 'Intersect': Louisiana Program Helps Patients Understand and Manage Medications</title>
      <link>https://www.ruralhealthinfo.org/rural-monitor/intersect-program</link>
      <description>Features a program at Arbor Family Health in Louisiana that connects chronic disease patients with nurse health coaches and clinical pharmacists. Shares how pharmacy faculty and students from the Xavier University of Louisiana's College of Pharmacy conduct annual comprehensive medication reviews by phone. -- Rural Health Information Hub</description>
      <guid>https://www.ruralhealthinfo.org/resources/27935</guid>
      <pubDate>Wed, 13 May 2026 13:13:23 -0500</pubDate>
    </item>
    <item>
      <title>Resource: April 2026 MedPAC Meeting Transcript</title>
      <link>https://www.medpac.gov/wp-content/uploads/2025/08/April-2026-public-meeting-transcript-SEC.pdf</link>
      <description>Transcript from the Medicare Payment Advisory Commission's (MedPAC) April 2026 meeting. Covers Medicare payment incentives, regional benchmarks and benchmark-plan availability in the Part D prescription drug plan (PDP) market, preferred networks and pharmacy access in Medicare Part D, the estimated association between Medicare Advantage enrollment and hospitals' and post-acute care providers' finances, information sources that beneficiaries use to make Medicare enrollment decisions, and institutional special-needs plans. Includes a mandated report on the assessment of the Medicare ground ambulance data collection system. Includes rural references and considerations throughout. -- Medicare Payment Advisory Commission</description>
      <guid>https://www.ruralhealthinfo.org/resources/27770</guid>
      <pubDate>Tue, 14 Apr 2026 10:52:21 -0500</pubDate>
    </item>
    <item>
      <title>Resource: Unapologetically Built Backwards: ONU HealthWise, Pharmacist-Driven Healthcare Access in Rural Ohio</title>
      <link>https://www.ruralhealthinfo.org/rural-monitor/onu-healthwise</link>
      <description>Features a university pharmacy department in rural Ohio that prepares pharmacy students for rural practice while also providing mobile services in nearby rural counties. Describes how the program has expanded to offer interprofessional education experiences and serve a larger region. -- Rural Health Information Hub</description>
      <guid>https://www.ruralhealthinfo.org/resources/27630</guid>
      <pubDate>Wed, 25 Mar 2026 14:33:18 -0500</pubDate>
    </item>
    <item>
      <title>Resource: Barriers to Implementing a Pharmacist-Led COPD CARE Bundle in Rural Settings: A Qualitative Evaluation</title>
      <link>https://bmjopenrespres.bmj.com/content/13/1/e003178</link>
      <description>Examines barriers to implementing the COPD Coordinated Access to Reduce Exacerbations (COPD CARE) program, a care bundle focused on improving chronic obstructive pulmonary disease care coordination among pharmacists, nurse care managers, and other pharmacy clinicians in the Veterans Affairs system. Describes themes from clinician interviews, including discussion of staffing challenges, limited referral availability, fragmentation of care, technological limitations, and more.</description>
      <guid>https://www.ruralhealthinfo.org/resources/27551</guid>
      <pubDate>Thu, 12 Mar 2026 12:11:04 -0500</pubDate>
    </item>
    <item>
      <title>Resource: Rural Health System Administrator Perspectives on Pharmacists' Role in Collaborative Drug Therapy Management</title>
      <link>https://www.japha.org/article/S1544-3191(25)00608-9/fulltext</link>
      <description>Examines the impact of pharmacist-led collaborative drug therapy modification (CDTM) on access to patient care in rural Georgia. Utilizes interview feedback from 7 primary healthcare system administrators regarding CDTM benefits and barriers, such as patient access to care, interprofessional collaboration among healthcare professionals, pharmacist knowledge and scope of practice, financial impacts, and more.</description>
      <guid>https://www.ruralhealthinfo.org/resources/27356</guid>
      <pubDate>Tue, 17 Feb 2026 09:45:27 -0600</pubDate>
    </item>
    <item>
      <title>Resource: Pharmacy Barriers to Receiving Buprenorphine among Patients Undergoing Telemedicine Addiction Treatment</title>
      <link>https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2837665</link>
      <description>Presents a study exploring pharmacy-level barriers&#13;
experienced by patients with opioid use disorder who are&#13;
receiving treatment via telemedicine. Discusses barriers&#13;
that lead to missed doses or inaccessible prescriptions.&#13;
Breaks down data by health and demographic characteristics,&#13;
such as age, education, and insurance type, among others,&#13;
and whether the patient lived in a rural or nonrural area.</description>
      <guid>https://www.ruralhealthinfo.org/resources/26339</guid>
      <pubDate>Thu, 22 Jan 2026 10:39:51 -0600</pubDate>
    </item>
    <item>
      <title>Resource: High Prescription Drug Out-of-Pocket Spending Burden among Privately Insured Rural and Urban Adults Age 18-64</title>
      <link>https://digitalcommons.usm.maine.edu/cgi/viewcontent.cgi?article=1004&amp;context=all_mrhrc</link>
      <description>Analyzes prescription drug out-of-pocket spending among privately-insured rural and urban adults, utilizing 2017-2020 Medical Expenditure Panel Survey (MEPS) data. Compares average spending and high prescription out-of-pocket burden in rural and urban populations, and details implications for rural medication adherence and associated health outcomes. -- Maine Rural Health Research Center</description>
      <guid>https://www.ruralhealthinfo.org/resources/27124</guid>
      <pubDate>Thu, 08 Jan 2026 10:52:21 -0600</pubDate>
    </item>
    <item>
      <title>Resource: How USPS Network Changes Threaten Prescription Drug Access for Vulnerable Populations</title>
      <link>https://www.brookings.edu/articles/how-usps-network-changes-threaten-prescription-drug-access-for-vulnerable-populations/</link>
      <description>Discusses the impact of mail processing changes on mail-order medication and asthma and diabetes management for rural communities. Highlights the "triple burden" of limited pharmacy access, high use of mail-order prescriptions, and proximity to postal service restructuring. Includes rural and urban comparisons, Medicare data, and county-level analysis. -- The Brookings Institution</description>
      <guid>https://www.ruralhealthinfo.org/resources/26953</guid>
      <pubDate>Tue, 09 Dec 2025 11:45:55 -0600</pubDate>
    </item>
    <item>
      <title>Resource: Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center Final Rule (CMS-1834-FC)</title>
      <link>https://www.cms.gov/newsroom/fact-sheets/calendar-year-2026-hospital-outpatient-prospective-payment-system-opps-ambulatory-surgical-center</link>
      <description>Fact sheet providing an overview of the Centers for&#13;
Medicare &amp; Medicaid Services (CMS) final rule regarding&#13;
updates and changes to the Medicare payments for hospital&#13;
outpatient and Ambulatory Surgical Center (ASC) services&#13;
for calendar year 2026. Summarizes provisions regarding&#13;
changes to hospital price transparency; Intensive&#13;
Outpatient Program (IOP) and partial hospital program rate&#13;
setting; updates to the Hospital Outpatient Quality&#13;
Reporting (OQR), Ambulatory Surgical Center Quality&#13;
Reporting (ASCQR), and Rural Emergency Hospital Quality&#13;
Reporting (REHQR) Programs; hospital quality start ratings;&#13;
and more. -- Centers for Medicare &amp; Medicaid Services</description>
      <guid>https://www.ruralhealthinfo.org/resources/26893</guid>
      <pubDate>Fri, 28 Nov 2025 16:00:00 -0600</pubDate>
    </item>
    <item>
      <title>Resource: Innovations in Pharmacy Training and Sustainable Practice to Advance Patient Care: Proceedings of a Workshop (2025)</title>
      <link>https://www.nationalacademies.org/read/29229</link>
      <description>Proceedings from a workshop convened May 29-30, 2025, exploring opportunities and challenges in pharmacy. Features sections on pharmacy deserts and workforce, financial sustainability, education and training programs, and recommendations for the future. Mentions rural throughout. -- Health and Medicine Division (HMD), National Academies of Sciences, Engineering, and Medicine</description>
      <guid>https://www.ruralhealthinfo.org/resources/26766</guid>
      <pubDate>Wed, 12 Nov 2025 15:29:28 -0600</pubDate>
    </item>
    <item>
      <title>Resource: Drone-Based Medication Delivery for Rural, Flood-Prone Coastal Communities</title>
      <link>https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0333696</link>
      <description>Discusses access to essential medical services and healthcare for rural communities in Virginia's flood-prone Eastern Shore. Utilizes geospatial data to examine the impact of drone-based medication delivery to overcome transportation barriers in these communities.</description>
      <guid>https://www.ruralhealthinfo.org/resources/26502</guid>
      <pubDate>Tue, 07 Oct 2025 09:48:06 -0500</pubDate>
    </item>
    <item>
      <title>Resource: The 340B Drug Discount Program: Litigation Topics and Trends</title>
      <link>https://www.congress.gov/crs_external_products/R/PDF/R48696/R48696.2.pdf</link>
      <description>Provides an overview of the 340B Drug Discount Program. Discusses litigation surrounding the 340B program, including lawsuits against 340B-covered entities over their use of contract pharmacies to distribute 340B drugs to patients and lawsuits against states that have enacted laws to protect contract pharmacies and covered entities inside their state. Describes courts' interpretation of the 340B statute. Offers considerations for the 119th Congress in light of the litigation and describes several legislative changes that Congress could make to the program if it chose to do so. -- Congressional Research Service</description>
      <guid>https://www.ruralhealthinfo.org/resources/26309</guid>
      <pubDate>Wed, 10 Sep 2025 11:48:33 -0500</pubDate>
    </item>
    <item>
      <title>Resource: Growth in the 340B Drug Pricing Program</title>
      <link>https://www.cbo.gov/system/files/2025-09/60661-340B-program.pdf</link>
      <description>Explores trends in drug purchases through the 340B program between 2010-2021. Discusses drugs purchased through the Prime Vendor Program, factors contributing to growth in the 340B program, and effects of the 340B program on the federal budget. Includes information on the growth of 340B Program participation by hospitals in Medicaid expansion and non-expansion states by Critical Access Hospital designation. -- Congressional Budget Office</description>
      <guid>https://www.ruralhealthinfo.org/resources/26308</guid>
      <pubDate>Wed, 10 Sep 2025 11:06:31 -0500</pubDate>
    </item>
    <item>
      <title>Resource: Rural Beneficiary Access to Medicare Advantage-Part D Plans</title>
      <link>https://rupri.public-health.uiowa.edu/publications/policybriefs/2025/Rural%20Access%20to%20Part%20D%20Plans.pdf</link>
      <description>Policy brief updating RUPRI's analysis of Medicare Advantage-Part D plans (MA-PDs) including enhanced benefit plan availability and differences in characteristics across metropolitan, micropolitan, and noncore areas. Features statistics including number of MA-PDs and stand-alone prescription drug plans (PDPs), average monthly premium costs, and availability in metropolitan, micropolitan, and noncore areas from 2008-2023. -- RUPRI Center for Rural Health Policy Analysis</description>
      <guid>https://www.ruralhealthinfo.org/resources/26239</guid>
      <pubDate>Fri, 29 Aug 2025 10:53:48 -0500</pubDate>
    </item>
    <item>
      <title>Event: 2026 Annual 340B Coalition Summer Conference</title>
      <link>https://www.340bwinterconference.org/</link>
      <description>Washington DC&lt;br&gt;July 13, 2026</description>
      <guid>https://www.ruralhealthinfo.org/events/24557</guid>
      <pubDate>Wed, 27 Aug 2025 08:40:47 -0500</pubDate>
    </item>
    <item>
      <title>Resource: Congress Must Act to Bring Needed Reforms to the 340B Drug Pricing Program: Majority Staff Report</title>
      <link>https://www.help.senate.gov/imo/media/doc/final_340b_majority_staff_reportpdf.pdf</link>
      <description>Presents findings from a U.S. Senate Committee on Health, Education, Labor &amp; Pensions majority staff report on how covered entities generate and use revenue from the 340B Drug Pricing Program and how patients benefit from the program. Describes data and information collected from hospital covered entities, Bon Secours Mercy Health and Cleveland Clinic; Federally Qualified Health Center (FQHC) covered entities, Sun River Health and Yakima Valley Farm Workers Clinic; contract pharmacies, CVS Health and Walgreens; and drug manufacturers, Eli Lilly and Amgen. Includes rural references throughout. -- Senate Committee on Health, Education, Labor &amp; Pensions</description>
      <guid>https://www.ruralhealthinfo.org/resources/25473</guid>
      <pubDate>Thu, 24 Apr 2025 09:09:08 -0500</pubDate>
    </item>
    <item>
      <title>Resource: Projecting the Impact of the $2,000 Part D Out-Of-Pocket Cap for Medicare Part D Enrollees with High Prescription Drug Spending</title>
      <link>https://aspe.hhs.gov/sites/default/files/documents/ee9b0f2bf15e69d7e3c7ca7618eaa2af/projecting-impact-part-d.pdf</link>
      <description>Examines the impact of the Medicare Part D $2,000 cap on out-of-pocket prescription drugs. Provides projected savings according to low-income subsidy (LIS) status, state, and demographic characteristics, including urban, rural-micropolitan, rural-other, or unclassified geographic location. -- HHS Office of the Assistant Secretary for Planning and Evaluation</description>
      <guid>https://www.ruralhealthinfo.org/resources/25013</guid>
      <pubDate>Thu, 16 Jan 2025 14:32:45 -0600</pubDate>
    </item>
    <item>
      <title>Resource: Screening and Referral Programs for Diabetes and Cardiovascular Disease: Can Community Pharmacists Bridge the Care Gap?</title>
      <link>https://www.sciencedirect.com/science/article/pii/S2667276624001367</link>
      <description>Examines the community-based valued-driven care initiative (CVCI) in community pharmacies to evaluate its effectiveness related to screening and referral (S&amp;R) to treat cardiovascular disease (CVD) and diabetes mellitus (DM). Analyzes patient demographics and success rates of CVD and DM S&amp;R in 6 community pharmacies, with both rural and urban locations represented.</description>
      <guid>https://www.ruralhealthinfo.org/resources/24815</guid>
      <pubDate>Fri, 20 Dec 2024 09:13:49 -0600</pubDate>
    </item>
    <item>
      <title>Resource: Buprenorphine Injection among Rural Persons Who Inject Drugs</title>
      <link>https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2827757</link>
      <description>Describes buprenorphine use by rural people who inject&#13;
drugs, using data from the Rural Opioid Initiative, to&#13;
inform patient-clinician discussions and public health&#13;
interventions. Features demographics and behavioral&#13;
characteristics of 2,369 people who were surveyed between&#13;
2018-2020.</description>
      <guid>https://www.ruralhealthinfo.org/resources/24760</guid>
      <pubDate>Thu, 12 Dec 2024 15:07:24 -0600</pubDate>
    </item>
    <item>
      <title>Resource: Pharmacy-Based Preventive Services for Opioid Use Disorder: A Survey of U.S. Pharmacists</title>
      <link>https://link.springer.com/article/10.1186/s13722-024-00519-w</link>
      <description>Examines pharmacist perceptions related to addressing opioid use disorder (OUD) and substance use disorder (SUD) in their patients. Utilizes online survey data from 1,146 pharmacists to analyze pharmacist concerns about drug use; drug screenings, interventions, and referrals; and commitment and readiness to address OUD and SUD in their patients. Includes breakdowns of pharmacist demographics as well as rurality of pharmacy locations.</description>
      <guid>https://www.ruralhealthinfo.org/resources/24669</guid>
      <pubDate>Mon, 02 Dec 2024 09:34:13 -0600</pubDate>
    </item>
    <item>
      <title>Resource: Community Responses and Adaptations Following the Closure of a Rural Pharmacy and Primary Care Facility</title>
      <link>https://onlinelibrary.wiley.com/doi/full/10.1111/jrh.12896</link>
      <description>Uses interviews with 26 community members to identify the impact of a pharmacy and primary healthcare facility closure in a rural Pennsylvania community. Discusses challenges for vulnerable populations, distance to care, social networks, delayed treatment, emergency medical services, alternative medicine, and more.</description>
      <guid>https://www.ruralhealthinfo.org/resources/24501</guid>
      <pubDate>Fri, 08 Nov 2024 09:50:10 -0600</pubDate>
    </item>
    <item>
      <title>Resource: Ensuring Access To Care: 340B Arrangements with Community and Specialty Pharmacies Improve Access to Care for Underserved Patients</title>
      <link>https://www.aha.org/system/files/media/file/2024/09/Ensuring-Access-to-Care-340B-Arrangements-with-Community-and-Specialty-Pharmacies-Improve-Access-to-Care.pdf</link>
      <description>Provides an overview of the 340B Drug Pricing Program, related legislation, benefits to underserved communities, relationship to specialty and community pharmacies, and more. Includes discussion on the value of the 340B program for rural pharmacies. -- American Hospital Association</description>
      <guid>https://www.ruralhealthinfo.org/resources/24040</guid>
      <pubDate>Tue, 10 Sep 2024 09:23:45 -0500</pubDate>
    </item>
    <item>
      <title>Resource: Prescription Medication Use, Coverage, and Nonadherence Among Adults Age 65 and Older: United States, 2021–2022</title>
      <link>https://www.cdc.gov/nchs/data/nhsr/nhsr209.pdf</link>
      <description>Reports on medication use, prescription drug insurance coverage, and nonadherence due to cost for older adults between 2021 and 2022. Includes data breakdown of various demographic and health status characteristics including 4 levels of urbanization. -- National Center for Health Statistics</description>
      <guid>https://www.ruralhealthinfo.org/resources/24009</guid>
      <pubDate>Thu, 05 Sep 2024 09:42:15 -0500</pubDate>
    </item>
  </channel>
</rss>
